Product Details for ANDA 063221
CEFTAZIDIME SODIUM IN PLASTIC CONTAINER (CEFTAZIDIME SODIUM)
EQ 10MG BASE/ML
Marketing Status: Discontinued
EQ 20MG BASE/ML
Marketing Status: Discontinued
EQ 40MG BASE/ML
Marketing Status: Discontinued
EQ 10MG BASE/ML
Marketing Status: Discontinued
Active Ingredient: CEFTAZIDIME SODIUM
Proprietary Name: CEFTAZIDIME SODIUM IN PLASTIC CONTAINER
Dosage Form; Route of Administration: INJECTABLE; INJECTION
Strength: EQ 10MG BASE/ML
Reference Listed Drug: No
Reference Standard: No
TE Code:
Application Number: A063221
Product Number: 001
Approval Date: Apr 29, 1993
Applicant Holder Full Name: BAXTER HEALTHCARE CORP
Marketing Status: Discontinued
Patent and Exclusivity Information
CEFTAZIDIME SODIUM IN PLASTIC CONTAINER (CEFTAZIDIME SODIUM)
Proprietary Name: CEFTAZIDIME SODIUM IN PLASTIC CONTAINER
Dosage Form; Route of Administration: INJECTABLE; INJECTION
Strength: EQ 10MG BASE/ML
Reference Listed Drug: No
Reference Standard: No
TE Code:
Application Number: A063221
Product Number: 001
Approval Date: Apr 29, 1993
Applicant Holder Full Name: BAXTER HEALTHCARE CORP
Marketing Status: Discontinued
Patent and Exclusivity Information
EQ 20MG BASE/ML
Marketing Status: Discontinued
Active Ingredient: CEFTAZIDIME SODIUM
Proprietary Name: CEFTAZIDIME SODIUM IN PLASTIC CONTAINER
Dosage Form; Route of Administration: INJECTABLE; INJECTION
Strength: EQ 20MG BASE/ML
Reference Listed Drug: No
Reference Standard: No
TE Code:
Application Number: A063221
Product Number: 002
Approval Date: Apr 29, 1993
Applicant Holder Full Name: BAXTER HEALTHCARE CORP
Marketing Status: Discontinued
Patent and Exclusivity Information
CEFTAZIDIME SODIUM IN PLASTIC CONTAINER (CEFTAZIDIME SODIUM)
Proprietary Name: CEFTAZIDIME SODIUM IN PLASTIC CONTAINER
Dosage Form; Route of Administration: INJECTABLE; INJECTION
Strength: EQ 20MG BASE/ML
Reference Listed Drug: No
Reference Standard: No
TE Code:
Application Number: A063221
Product Number: 002
Approval Date: Apr 29, 1993
Applicant Holder Full Name: BAXTER HEALTHCARE CORP
Marketing Status: Discontinued
Patent and Exclusivity Information
EQ 40MG BASE/ML
Marketing Status: Discontinued
Active Ingredient: CEFTAZIDIME SODIUM
Proprietary Name: CEFTAZIDIME SODIUM IN PLASTIC CONTAINER
Dosage Form; Route of Administration: INJECTABLE; INJECTION
Strength: EQ 40MG BASE/ML
Reference Listed Drug: No
Reference Standard: No
TE Code:
Application Number: A063221
Product Number: 003
Approval Date: Apr 29, 1993
Applicant Holder Full Name: BAXTER HEALTHCARE CORP
Marketing Status: Discontinued
Patent and Exclusivity Information
Proprietary Name: CEFTAZIDIME SODIUM IN PLASTIC CONTAINER
Dosage Form; Route of Administration: INJECTABLE; INJECTION
Strength: EQ 40MG BASE/ML
Reference Listed Drug: No
Reference Standard: No
TE Code:
Application Number: A063221
Product Number: 003
Approval Date: Apr 29, 1993
Applicant Holder Full Name: BAXTER HEALTHCARE CORP
Marketing Status: Discontinued
Patent and Exclusivity Information